This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Compare retirement index funds to see which has the lowest fees while meeting your risk and diversification goals.
28,038 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
NATO defense budgets surged to fresh records as members commit to larger, longer-term modernization. Three ETFs offer...
SpaceX is making waves in public markets with headlines about rapid gains and sky-high valuations. This article cuts ...
As 2026 unfolds, silver and copper lead gains while gold pauses. Three ETFs illustrate how investors are positioning ...
The Fed is dialed into inflation that won’t quit. Even with cooling CPI numbers, prices stay stubborn in key areas. H...
Chubb sits as a stalwart in global insurance, trading at roughly 12x earnings. This article breaks down what that mea...
When big names place bets, markets listen. This piece breaks down what cathie wood buying cerebras could mean for you...
U.S. adults now smoke at a record low, but a shift in public-health funding threatens the playbook that drove the dec...
When chip stocks tumble, investors face tough choices. This guide breaks down whether Nvidia, Broadcom, and Cerebras ...
A durable industrial leader with long-term contracts stands out as markets tilt toward defensives. Here’s why this in...
Amgen's dividend has powered income-focused portfolios for years, but regulatory and pricing challenges raise questio...
Axiom Space has closed a $350 million round to accelerate its private space station project. This milestone highlight...